164 related articles for article (PubMed ID: 25602791)
21. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
Wentzensen N; Schwartz L; Zuna RE; Smith K; Mathews C; Gold MA; Allen RA; Zhang R; Dunn ST; Walker JL; Schiffman M
Clin Cancer Res; 2012 Aug; 18(15):4154-62. PubMed ID: 22675168
[TBL] [Abstract][Full Text] [Related]
22. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
23. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
Uijterwaal MH; Polman NJ; Witte BI; van Kemenade FJ; Rijkaart D; Berkhof J; Balfoort-van der Meij GA; Ridder R; Snijders PJ; Meijer CJ
Int J Cancer; 2015 May; 136(10):2361-8. PubMed ID: 25345358
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
Yu LL; Chen W; Lei XQ; Qin Y; Wu ZN; Pan QJ; Zhang X; Chang BF; Zhang SK; Guo HQ; Qiao YL
Oncotarget; 2016 Apr; 7(16):21181-9. PubMed ID: 27029033
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and grading of cervical intraepithelial neoplasias].
Rosamilia C; Feichter G; Tzankov A; Obermann EC
Pathologe; 2012 Mar; 33(2):118-23. PubMed ID: 22350168
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of p16INK4a immunostaining for the detection of high-grade changes in cervical cytology.
Tabrizi SN; Tan SE; von Knebel Doeberitz C; Tan J; Quinn MA; Garland SM
Pathology; 2015 Jun; 47(4):314-9. PubMed ID: 25938364
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of p16 immunostaining to predict high-grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance.
Guo M; Warriage I; Mutyala B; Patel S; Lin E; Gong Y; Sneige N
Diagn Cytopathol; 2011 Jul; 39(7):482-8. PubMed ID: 20607682
[TBL] [Abstract][Full Text] [Related]
28. Covariates of high-risk human papillomavirus (HPV) infections are distinct for incident CIN1, CIN2 and CIN3 as disclosed by competing-risks regression models.
Syrjänen K; Shabalova I; Sarian L; Naud P; Longatto-Filho A; Derchain S; Kozachenko V; Zakharchenko S; Roteli-Martins C; Nerovjna R; Kljukina L; Tatti S; Branovskaja M; Branca M; Grunjberga V; Erzen M; Juschenko A; Serpa Hammes L; Podistov J; Costa S; Syrjänen S; ;
Eur J Gynaecol Oncol; 2012; 33(1):5-14. PubMed ID: 22439398
[TBL] [Abstract][Full Text] [Related]
29. Performance of HPV E4 and p16
Damgaard RK; Jenkins D; de Koning MN; Quint WG; Stoler MH; Doorbar J; Kahlert J; Gravitt PE; Steiniche T; Petersen LK; Hammer A
BMJ Open; 2022 Jul; 12(7):e059593. PubMed ID: 35793925
[TBL] [Abstract][Full Text] [Related]
30. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
[TBL] [Abstract][Full Text] [Related]
31. Triaging HPV-positive, cytology-negative cervical cancer screening results with extended HPV genotyping and p16
Song F; Yan P; Huang X; Wang C; Qu X; Du H; Wu R
BMC Infect Dis; 2021 Apr; 21(1):400. PubMed ID: 33931022
[TBL] [Abstract][Full Text] [Related]
32. Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology.
Petry KU; Schmidt D; Scherbring S; Luyten A; Reinecke-Lüthge A; Bergeron C; Kommoss F; Löning T; Ordi J; Regauer S; Ridder R
Gynecol Oncol; 2011 Jun; 121(3):505-9. PubMed ID: 21420158
[TBL] [Abstract][Full Text] [Related]
33. Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
Howitt BE; Nucci MR; Drapkin R; Crum CP; Hirsch MS
Am J Surg Pathol; 2013 Jan; 37(1):89-97. PubMed ID: 23211296
[TBL] [Abstract][Full Text] [Related]
34. p16(INK4a) Expression does not predict the outcome of cervical intraepithelial neoplasia grade 2.
Guedes AC; Brenna SM; Coelho SA; Martinez EZ; Syrjänen KJ; Zeferino LC
Int J Gynecol Cancer; 2007; 17(5):1099-103. PubMed ID: 17367324
[TBL] [Abstract][Full Text] [Related]
35. Expression of geminin, p16, and Ki67 in cervical intraepithelial neoplasm and normal tissues.
Xing Y; Wang C; Wu J
Medicine (Baltimore); 2017 Jun; 96(26):e7302. PubMed ID: 28658133
[TBL] [Abstract][Full Text] [Related]
36. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
Ikenberg H; Bergeron C; Schmidt D; Griesser H; Alameda F; Angeloni C; Bogers J; Dachez R; Denton K; Hariri J; Keller T; von Knebel Doeberitz M; Neumann HH; Puig-Tintore LM; Sideri M; Rehm S; Ridder R;
J Natl Cancer Inst; 2013 Oct; 105(20):1550-7. PubMed ID: 24096620
[TBL] [Abstract][Full Text] [Related]
37. Using biomarkers as objective standards in the diagnosis of cervical biopsies.
Galgano MT; Castle PE; Atkins KA; Brix WK; Nassau SR; Stoler MH
Am J Surg Pathol; 2010 Aug; 34(8):1077-87. PubMed ID: 20661011
[TBL] [Abstract][Full Text] [Related]
38. Prognostic role of immunohistochemical overexpression of the p16 protein in women under the age of 35 and diagnosed with HSIL (CIN2) subjected to "cervix sparing" excision.
Lukic A; Rossi S; Frega A; Ruscito I; Bianchi P; Nobili F; Caserta D; Vecchione A
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1261-1273. PubMed ID: 33629296
[TBL] [Abstract][Full Text] [Related]
39. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
Ebisch RMF; Rijstenberg LL; Soltani GG; van der Horst J; Vedder JEM; Hermsen M; Bosgraaf RP; Massuger LFAG; Meijer CJLM; Heideman DAM; van Kemenade FJ; Melchers WJG; Bekkers RLM; Siebers AG; Bulten J
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1328-1336. PubMed ID: 36177908
[TBL] [Abstract][Full Text] [Related]
40. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
White CM; Bakhiet S; Bates M; Ruttle C; Pilkington LJ; Keegan H; O'Toole SA; Sharp L; O'Kelly R; Tewari P; Flannelly G; Martin CM; O'Leary JJ;
Cancer Epidemiol; 2020 Oct; 68():101793. PubMed ID: 32841926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
